Works matching IS 25094254 AND DT 2025 AND VI 9 AND IP 2

Results: 14

Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data: Cost-Effectiveness of NIVO+IPI for NSCLC Using Mixture-Cure Survival Analysis: A. D. Griffiths et al

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 247, doi. 10.1007/s41669-024-00545-z

By:

Griffiths, Alison D.;
Young, Robert O.;
Yuan, Yong;
Chaudhary, Mohammad A.;
Lee, Adam;
Gordon, Jason;
McEwan, Philip

Publication type:

Article

Correction: From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment: Correction: From Clinical to Non-clinical Outcomes in the Treatment of HIV: L. Ferrario et al.

Published in:

2025

By:

Ferrario, Lucrezia;
Menzaghi, Barbara;
Rizzardini, Giuliano;
Roccia, Alessandro;
Garagiola, Elisabetta;
Bellavia, Daniele;
Schettini, Fabrizio;
Foglia, Emanuela

Publication type:

Correction Notice

Cost-Utility Analysis of LifeVest® in Post-Myocardial Infarction Patients at Risk of Sudden Cardiac Death in England: Cost-Utility Analysis of WCD in England: V. Kontogiannis et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 301, doi. 10.1007/s41669-024-00553-z

By:

Kontogiannis, Vasileios;
Goromonzi, Farai;
Both, Brigitte;
Semrau, Frank;
Branagan-Harris, Michael;
Atkinson, Jowan;
Roberts, Paul R.;
Javanbakht, Mehdi

Publication type:

Article

What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency: What Does Pharmaceutical 3D Printing Cost: S. Ayyoubi et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 207, doi. 10.1007/s41669-024-00551-1

By:

Ayyoubi, Sejad;
Ruijgrok, Liesbeth;
van der Kuy, Hugo;
ten Ham, Renske;
Thielen, Frederick

Publication type:

Article

Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany: Complications and HCRU of SCD with Recurrent VOCs and TDT: C. Udeze et al

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 291, doi. 10.1007/s41669-024-00550-2

By:

Udeze, Chuka;
Li, Nanxin;
Kunzweiler, Colin;
Baldwin, Jessica;
Tuzin, Petra;
Zingel, Sebastian Dietmar;
Vetter, Céline;
Dombrowski, Silvia;
Georgiadou-Schmidt, Elena;
Alba, Aranzazu;
Meisel, Roland

Publication type:

Article

Correction: Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data: Mapping WHODAS 2.0 onto SF-6D: A. Philipson et al.

Published in:

2025

By:

Philipson, Anna;
Hagberg, Lars;
Hermansson, Liselotte;
Karlsson, Jan;
Ohlsson-Nevo, Emma;
Ryen, Linda

Publication type:

Correction Notice

Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients' Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany: Collaborative Dementia Care Management in Different Settings: M. Platen et al

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 271, doi. 10.1007/s41669-024-00548-w

By:

Platen, Moritz;
Hoffmann, Wolfgang;
Michalowsky, Bernhard

Publication type:

Article

Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium: Economic Impact of Reduced Insulin Pen Needle Reuse: K. Theys et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 259, doi. 10.1007/s41669-024-00547-x

By:

Theys, Kristof;
Vermander, Sofie;
Annemans, Lieven;
De Block, Christophe;
Hermans, Michel P.;
Matthys, Imke;
Nobels, Frank;
Nguyen, Trung;
Preumont, Vanessa;
Zakrzewska, Katerina;
Vanderdonck, Frank

Publication type:

Article

The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey: COVID-19 and economic outcomes: S. W. Kim et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 231, doi. 10.1007/s41669-024-00544-0

By:

Kim, Sung Wook;
Alacevich, Caterina;
Nicodemo, Catia;
Wittenberg, Raphael;
de Lusignan, Simon;
Petrou, Stavros

Publication type:

Article

Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis: Burden of Disease of Breast Cancer in Italy: F. S. Mennini et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 283, doi. 10.1007/s41669-024-00543-1

By:

Mennini, F. S.;
Marcellusi, A.;
Sciattella, P.;
Scortichini, M.;
Ragonese, Angela;
Cattel, F.;
D'Antona, R.;
Del Mastro, L.;
Gori, S.;
Perrone, G.;
Migliorini, R.;
Trabucco Aurilio, M.

Publication type:

Article

From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment: Economic and Organizational Impact Assessment in the Treatment of HIV: L. Ferrario et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 313, doi. 10.1007/s41669-024-00542-2

By:

Ferrario, Lucrezia;
Menzaghi, Barbara;
Rizzardini, Giuliano;
Roccia, Alessandro;
Garagiola, Elisabetta;
Bellavia, Daniele;
Schettini, Fabrizio;
Foglia, Emanuela

Publication type:

Article

Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India: Economic Evaluation for Knee Osteoarthritis Management in India: A. S. Qadeer et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 217, doi. 10.1007/s41669-024-00541-3

By:

Qadeer, Amatullah Sana;
Meher, Ananda;
Rachel, Jennifer;
Paulson, Winnie;
Patra, Abhilash;
Gandhi, Naline;
AY, Nirupama;
Nanda, Lipika;
Rout, Sarit Kumar;
Dutta, Ambarish

Publication type:

Article

Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review: Economic Burden of Haemophilia from a Societal Perspective: A. A. El-Sayed, N. S. Bolous.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 179, doi. 10.1007/s41669-024-00540-4

By:

El-Sayed, Amr A.;
Bolous, Nancy S.

Publication type:

Article

Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations: Incorporating Resource Constraints in Health Economic Evaluations: P. Thokala et al.

Published in:

PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 161, doi. 10.1007/s41669-024-00537-z

By:

Thokala, Praveen;
Duarte, Henrique;
Wright, Stuart;
Husereau, Don;
Durand-Zaleski, Isabelle;
Lindgren, Peter;
Postema, Roelien;
Machnicki, Gerardo;
Garrison, Louis

Publication type:

Article